⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

Avalyn Pharma Inc. Common Stock

$25.76
+0.00 (+0.00%)

Volume:

144.896K ($3.73M)

Market Capitalization:

$1.14B

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

Avalyn Pharma Market Segments

Regular Trading Hours

+0.06(+0.23%)
Open$25.70
Close$25.76
Low$25.22
Low Change-0.48 (-1.87%)
High$26.33
High Change+0.63 (+2.43%)
Range$1.11
Volume143.125K
Dollar Volume$3.69M

Premarket

+0.41(+1.61%)
Open$25.50
Close$25.91
Low$25.50
Low Change0.00 (0.00%)
High$25.91
High Change+0.41 (+1.61%)
Range$0.41
Volume1.771K
Dollar Volume$45.89K

Overnight

*No Trades in Segment

After Hours Yesterday

+0.00(+0.00%)
Open$25.72
Close$25.72
Low$25.72
Low Change0.00 (0.00%)
High$25.72
High Change+0.00 (+0.00%)
Range$0.00
Volume150.861K
Dollar Volume$3.88M

Regular Trading Hours Yesterday

+0.44(+1.74%)
Open$25.32
Close$25.76
Low$24.14
Low Change-1.18 (-4.66%)
High$25.82
High Change+0.50 (+1.97%)
Range$1.68
Volume712.195K
Dollar Volume$18.35M

Premarket Yesterday

*No Trades in Segment

Avalyn Pharma Top Trades

Avalyn Pharma's top trade so far today returned +3.24%, while the top short trade returned -2.66%.

Avalyn Pharma Moving Averages

5 Day Moving Average (SMA5)$26.39
10 Day Moving Average (SMA10)$27.15
20 Day Moving Average (SMA20)$29.84
50 Day Moving Average (SMA50)$33.14
100 Day Moving Average (SMA100)$30.88
200 Day Moving Average (SMA200)—

Avalyn Pharma Statistics

Average Volume (30 Days)—
P/E Ratio (Current)—
EPS (Current)—
Dividend Yield—
Free Cash Flow—
Cash Ratio—
Current Ratio—
Quick Ratio—
Debt to Equity—
Enterprise Value—
EV to EBITDA—
EV to Sales—
Price to Book—
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets—
Return on Equity—

Avalyn Pharma Stock Splits

There has been 1 stock split for Avalyn Pharma (AVLN). The reverse stock split occured on September 25, 2007 and reduced the outstanding shares at a ratio of 3:1.

DateTypeRatio
Sep 25, 2007Reverse3:1

Avalyn Pharma Dividends

There have been no dividends for Avalyn Pharma (AVLN).